Subject Reported Outcomes With Use of Adapalene 0.3% - Benzoyl Peroxide (BPO) 2.5% in Dark Skin Acne
Clinical trial NCT02932267 · COMPLETED
Trial details
- NCT number
- NCT02932267
- Sponsor
- Galderma R&D
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-02
- Primary completion
- 2018-01-10
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.